{"id":1068403,"date":"2023-03-31T00:42:51","date_gmt":"2023-03-31T04:42:51","guid":{"rendered":"https:\/\/www.immortalitymedicine.tv\/spero-therapeutics-announces-fourth-quarter-and-full-year-2022-operating-results-and-provides-business-update\/"},"modified":"2024-08-18T11:46:48","modified_gmt":"2024-08-18T15:46:48","slug":"spero-therapeutics-announces-fourth-quarter-and-full-year-2022-operating-results-and-provides-business-update","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/spero-therapeutics-announces-fourth-quarter-and-full-year-2022-operating-results-and-provides-business-update.php","title":{"rendered":"Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update"},"content":{"rendered":"<p><![CDATA[Initiated proof-of-concept Phase 2 trial of SPR720 in nontuberculous mycobacterial pulmonary disease (NTM-PD); top line data expected in 1H 2024]]><\/p>\n<p>Read the original:<br \/>\n<a target=\"_blank\" rel=\"nofollow noopener\" href=\"https:\/\/www.globenewswire.com\/news-release\/2023\/03\/30\/2638177\/0\/en\/Spero-Therapeutics-Announces-Fourth-Quarter-and-Full-Year-2022-Operating-Results-and-Provides-Business-Update.html?f=22&amp;fvtc=5&amp;fvtv=46634288\" title=\"Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update\">Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p>Read the original: Spero Therapeutics Announces Fourth Quarter and Full Year 2022 Operating Results and Provides Business Update <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/global-news-feed\/spero-therapeutics-announces-fourth-quarter-and-full-year-2022-operating-results-and-provides-business-update.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":64,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[1246886],"tags":[],"class_list":["post-1068403","post","type-post","status-publish","format-standard","hentry","category-global-news-feed"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068403"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/64"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=1068403"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/1068403\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=1068403"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=1068403"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=1068403"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}